Clinical Trials Logo

Clinical Trial Summary

PPROSPERITIT is a prospective clinical study assessing the use of comprehensive molecular profiling to define the best matching targeted and immune treatment for relapsed, refractory or very high risk pediatric CNS tumors.


Clinical Trial Description

PPROSPERITIT will identify specific molecular changes by using genomic sequencing technologies in refractory/recurrent or very high-risk pediatric CNS tumors. The study will employ an analytically validated comparison of a selection of targeted agents/immune therapies on the basis of commercially available comprehensive genomic profiling FoundationOneHeme panel (F1Heme, comprising DNA and RNA analysis) vs selection of agents based on more complex DNA/RNA/Protein based analyses. This will be coupled to a computer algorithm that uses preexisting definitions and prioritization of target-agent pairs to assign patients by actionable mutation results to a targeted treatment. The selection of targeted agents will be performed by a multidisciplinary molecular tumor board, but the recommended treatment will not be a part of the PPROSPERTIT study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04859543
Study type Interventional
Source Masaryk University
Contact Kristyna Noskova, PhD
Phone 00 420 549 496 147
Email [email protected]
Status Recruiting
Phase N/A
Start date February 1, 2021
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT01645436 - Physical Activity in Pediatric Cancer (PAPEC) N/A
Recruiting NCT04409301 - Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation N/A
Not yet recruiting NCT04855487 - Nurse-Adolescent/Young Adult With Cancer Dyadic Storytelling Intervention N/A
Recruiting NCT03241251 - Screening for Psychosocial Risk in Flemish Families of a Child With Cancer
Completed NCT04586491 - The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients N/A
Completed NCT02665819 - Long Term Support for Pediatric Cancer Adult Survivors in Rhône-Alpes : Evaluation of Women Fertility. N/A
Completed NCT02675166 - Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes
Recruiting NCT02536183 - A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Phase 1
Withdrawn NCT01828502 - Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer Phase 2
Completed NCT02032121 - Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors N/A
Recruiting NCT03964259 - Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia Phase 1
Not yet recruiting NCT04483362 - CanMove: A Physical Activity Program for Children With Cancer N/A
Enrolling by invitation NCT04150120 - eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness N/A
Not yet recruiting NCT04547829 - Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy Phase 2
Not yet recruiting NCT04508400 - Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients Phase 2
Recruiting NCT04479514 - Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy Phase 2
Completed NCT04134429 - Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy
Recruiting NCT03739372 - Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma N/A
Recruiting NCT04613830 - Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients Phase 2/Phase 3